These results suggest that carcinoma cells could utilize extracellular VIM as a ligand to drive IGF-1R downstream signals; however, more work is needed to establish this, to determine if it occurs in other cancer types, and to characterize the functional outcomes of extracellular VIM-mediated signaling. The gene discussed is VIM; the disease is carcinoma.